MedTrace Logo

PAAG-OA Treatment for Knee Osteoarthritis

NCT04179552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2024-11-26

No results posted yet for this study

Summary

This is a multi-centre, prospective, open-label, uncontrolled, clinical investigation followed by an open-label extension clinical investigation to evaluate PAAG-OA in patients with knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

PAAG-OA

Intra-articular injection with PAAG-OA (polyacrylamide hydrogel)

Sponsors & Collaborators

  • Contura

    lead INDUSTRY

Principal Investigators

  • Henning Bliddal, MD · The Parker Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-21
Primary Completion
2020-02-07
Completion
2024-09-19

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04179552 on ClinicalTrials.gov